Market Tracker

04/16 5:15pm ET

Myriad Genetics Inc (NASDAQ:MYGN)

During the Trading Day
38.33 -0.42 / -1.08%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
38.33 0.00 / 0.00%
 
Volume: 4.2K

Today’s Trading

Previous close38.75
Today’s open39.17
Day’s range38.08 - 39.80
Volume1,751,475
Average volume (3 months)2,294,671
Market cap$2.8B
Dividend yield--
Data as of 3:59pm ET, 04/16/2014

Growth & Valuation

Earnings growth (last year)+36.15%
Earnings growth (this year)+24.29%
Earnings growth (next 5 years)+14.91%
Revenue growth (last year)+23.62%
P/E ratio16.5
Price/Sales3.55
Price/Book4.20

Competitors

 Today’s
change
Today’s
% change
NPSPNPS Pharmaceuticals ...+1.45+6.20%
MNKDMannkind Corp+0.11+1.75%
WXWuXi Pharmatech (Cay...+0.85+2.42%
PBYIPuma Biotechnology I...+0.59+0.82%
Data as of 4:02pm ET, 04/16/2014

Financials

Next reporting dateMay 6, 2014
EPS forecast (this quarter)$0.45
Annual revenue (last year)$613.2M
Annual profit (last year)$147.1M
Net profit margin24.00%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Peter D. Meldrum
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts